Medicare telehealth and DEA telemedicine flexibilities: what runs to when
Section 6209 of Public Law 119-75 extends certain Medicare telehealth flexibilities to December 31, 2027 and delays the in-person rule for mental health to January 1, 2028. DEA’s separate permission to prescribe controlled substances by telemedicine without an in-person visit runs through December 31, 2026.
Two separate sets of rules govern a telehealth visit. Medicare’s rules, in section 1834(m) of the Social Security Act, decide whether Medicare pays for a service delivered by telehealth. The Controlled Substances Act, as amended by the Ryan Haight Act, decides whether a practitioner may prescribe a controlled substance to a patient they have never seen in person. The two have different end dates, so one visit can fall inside one set of flexibilities and outside the other [1] [2].
Medicare: what section 6209 extends
Section 6209 of Public Law 119-75 amends the Social Security Act by striking the earlier end dates and inserting new ones [1]:
- Geography and originating sites (section 1834(m)(2)(B)(iii) and (4)(C)(iii)): the provisions the Act describes as removing geographic requirements and expanding originating sites now run through December 31, 2027.
- Eligible practitioners (section 1834(m)(4)(E)): the expanded list runs through December 31, 2027.
- Federally qualified health centers and rural health clinics (section 1834(m)(8)(A)): telehealth services run through December 31, 2027.
- Audio-only services (section 1834(m)(9)): through December 31, 2027.
- Hospice recertification (section 1814(a)(7)(D)(i)(II)): the face-to-face encounter may be conducted by telehealth through December 31, 2027, with exceptions from January 31, 2026 for patients in areas under a hospice enrollment moratorium, patients of hospices under enhanced oversight, and encounters by hospice physicians or nurse practitioners who are not enrolled in Medicare and have not opted out.
- Mental health in-person requirement (section 1834(m)(7)(B)(i), and the matching rural health clinic and FQHC provisions): applies to services furnished on or after January 1, 2028.
Each of the struck dates was January 30 or January 31, 2026 [1]. The DEA’s 2025 rule describes an earlier lapse: it says Medicare’s telemedicine flexibilities ceased on September 30, 2025, and that the cessation lasted 41 days [2].
New billing modifiers
Section 6209 also adds two coding requirements [1]:
- Not later than January 1, 2027, the Secretary must establish requirements for one or more codes or modifiers on telehealth claims furnished through a telehealth virtual platform where the practitioner contracts with, or has a payment arrangement with, the platform’s owner, and on telehealth services furnished incident to a practitioner’s professional service.
- For hospice face-to-face encounters by telehealth on or after January 1, 2027, the claim must include a modifier or code specified by the Secretary.
The Secretary may implement the section by program instruction or otherwise [1], so the operational detail may arrive as CMS instructions rather than a rulemaking.
DEA: prescribing without an in-person evaluation
Under the Ryan Haight Act, a practitioner may generally prescribe a controlled substance remotely only after at least one in-person medical evaluation of the patient. During the COVID-19 public health emergency, DEA granted temporary exceptions through two letters in March 2020 [2]. DEA and HHS have since extended them four times [2]:
- First Temporary Rule, May 10, 2023: through November 11, 2023, with a grace period to November 11, 2024 for relationships established by then.
- Second Temporary Rule, October 10, 2023: through December 31, 2024.
- Third Temporary Rule, November 19, 2024: through December 31, 2025.
- Fourth Temporary Rule, published December 31, 2025: effective January 1, 2026 through December 31, 2026.
Under the fourth rule, codified at 21 CFR 1307.41 and 42 CFR 12.1, a DEA-registered practitioner may prescribe Schedule II-V controlled substances by telemedicine to a patient without an in-person evaluation if all of these conditions are met [2]:
- the prescription is issued for a legitimate medical purpose in the usual course of professional practice;
- it follows a communication using an interactive telecommunications system referred to in 42 CFR 410.78(a)(3);
- the practitioner is authorized under their registration to prescribe that class of controlled substance, or is exempt from registration; and
- the prescription meets all other requirements of 21 CFR part 1306.
The two permanent rules alongside it
Two final rules published January 17, 2025, on buprenorphine treatment via telemedicine (21 CFR 1306.51) and continuity of care for Veterans Affairs patients (21 CFR 1306.52), had their effective date delayed to December 31, 2025, the date the fourth temporary rule says they go into effect. The DEA states that a practitioner may still prescribe under the temporary rule even when one of those rules would also apply, and that the temporary rule imposes fewer requirements [2].
A proposed special registration for telemedicine, published January 17, 2025, drew more than 6,475 comments [2]. DEA’s Diversion Control Division telemedicine page states that DEA is drafting updated regulations [3]. A Federal Register search of DEA documents mentioning telemedicine published since January 1, 2026, run on November 14, 2026, returned no extension or final telemedicine rule [4].
Dates to plan around
- December 31, 2026: DEA’s fourth temporary extension ends [2].
- January 1, 2027: deadline for Medicare’s new telehealth modifier requirements, and start of the hospice telehealth modifier rule [1].
- December 31, 2027: end of the Medicare telehealth flexibilities extended by section 6209 [1].
- January 1, 2028: Medicare’s in-person requirement for mental health telehealth applies [1].
In our view, the gap between the DEA and Medicare dates is the main operational risk for 2027. A practice can identify now which patients receive controlled substance prescriptions from a clinician who has never seen them in person, so that it can schedule in-person visits or move to another authority if no further extension arrives. That is a planning step, not a requirement.
This explainer describes the law and rules; it is not legal advice, and organizations should confirm with counsel how they apply to their services and state licensure.
Moraph’s teams help organizations with work like this. See our solutions.
Spotted an error? Tell us and we will check it and correct the explainer where needed.